Search

everythinglearnresearchcommunity

for

Search:↓

LC-OCT is a useful noninvasive tool for diagnosing and monitoring alopecia areata.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

Higher antigliadin antibody levels are linked to alopecia areata severity.

A 66-year-old woman experienced hair loss due to Frontal Fibrosing Alopecia, a condition with no consistently effective treatment, but it usually stabilizes over time. More research is needed for better understanding and treatment options.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

The study concludes that early diagnosis of Frontal Fibrosing Alopecia is important, as it is often found in postmenopausal women, may be related to Lichen Planopilaris, and eyebrow hair loss is a common sign.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

UVFD helps detect hair follicles in alopecia areata better than traditional methods.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.

The STRIAA tool helps doctors quickly and effectively assess the severity of Alopecia Areata.

A woman with systemic sclerosis developed a unique scarring hair loss combining features of systemic sclerosis and frontal fibrosing alopecia.

AUC and APL are distinct conditions needing careful clinical assessment.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

A new tool simplifies alopecia areata severity scoring but needs validation.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Frontal Fibrosing Alopecia is a slowly progressing hair loss condition, likely underdiagnosed, with ineffective treatments, needing more research to understand it fully.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Linalool in fragrances may harm hair follicles and contribute to hair loss.